- Current Research Into Pain Assessment
- Immunotherapy for Prostate Cancer
- Targeted Agents
- Targeted Agents (cont.)
- Treatment Sequencing
- Androgen Deprivation Therapy
- Duration of ADT
- Docetaxel in Combination With ADT
- ADT Resistance
- ADT and Radiation
- Predictions for the Future
Prostate Cancer News
First-Line Enzalutamide May Confer a Survival Benefit for Metastatic Castration-Resistant Prostate Cancer
More Prostate Cancer Information
Both the chemotherapy regimen selected and therapeutic dose intensity used in treatment factor into the calculation of neutropenia risk.
Traditional genetic testing historically included the sequential analysis of single and generally well-described genes involved in heritable cancers.
Some data suggest that psychotherapy may benefit patients with cancer, but higher-quality research is needed.
The effect of polypharmacy and noncancer mortality on patient survival and other outcomes in cancer varies by study.
Though it is clear that cancer is associated with an extreme financial burden, the extent of the burden varies widely.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|